Skip to main navigation Skip to main content


GOLD 2023 COPD Update: Controversies, opportunities, and relevance to Australian practice Members login for free access About RACGP online events


Type: Webinar
31 May, 7:00 PM - 8:00 PM (AEST)


For more information:
Email: RACGP Specific Interests
Call: 0386990071


RACGP Members: Free
Non-Members: Free

Free registration

GOLD 2023 COPD Update: Controversies, opportunities, and relevance to Australian practice

Webinar 31 May, 7:00 PM - 8:00 PM (AEST)

The GOLD 2023 Guidelines have been updated to reflect the body of evidence in the treatment and management of COPD. 

This session will outline the new GOLD 2023 Guidelines and their impact on clinical practice, with a focus on: 
-    Treatable traits and how they shape COPD treatment
-    Relevance of international guidelines on Australian practice and primary care
-    Principles for appropriate inhaler choice and environmental considerations 

Learning outcomes

  1. Identify the key changes and recommendations of the new GOLD global COPD Guidelines and their relevance to local practice
  2. Determine which patients would benefit from bronchodilator and/or inhaled corticosteroid therapy
  3. Differentiate between the different types of inhalers and recommend appropriate inhaler choice based on key principles


Dr Kerry Hancock
GP and Chair of RACGP Specific Interests, Respiratory Medicine

Dr Kerry Hancock is a General Practitioner and has over 38 years experience in clinical practice with most of that time as a principal of a self established practice in the outer southern suburbs of Adelaide. Dr Hancock’s active participation with respiratory organisations, government health services, research activities and RACGP has enabled her to be involved in the development of national primary care focused respiratory management guidelines, educational activities and the development and promulgation of tools to assist GPs, Practice Nurses and Pharmacists in the management of their patients with respiratory and related disorders. She is currently Chair RACGP Respiratory Medicine Specific Interests Group; Chair Lung Foundation Australia (LFA) Primary Care Clinical Council; member LFA Clinical and Research Council and COPD Clinical Advisory Committee; Honorary Fellow Allergy and Lung Health Unit Melbourne School of Population and Global Health The University of Melbourne; previous Principal Medical Officer and Board member / Director Asthma Foundation SA and previous Chair GP Asthma Group National Asthma Council.


A/Prof John Blakey
Consultant in Respiratory and sleep medicine, Sir Charles Gairdiner Hospital

A/Prof John Blakey is a Consultant in Respiratory and Sleep Medicine at Sir Charles Gairdner Hospital, Perth. He has clinical expertise in asthma and airways diseases. His main research interest is in health service delivery, particularly the move toward assessment of future risk as a key aspect of asthma care, and the use of newer connected technologies. His research has been published in leading journals such as The Lancet, JACI, Thorax, and AJRCCM. He continues to be research active through adjunct positions with Curtin University and UWA. He undertakes advisory and committee work for Asthma Australia and Asthma WA, and is WA branch President of TSANZ.



© 2023 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807